Inflammatory diet scores tracked with worse metabolic health in heavier adults
A higher dietary inflammatory index aligned with a greater likelihood of being metabolically unhealthy in Iranian adults who were overweight or obese. The association did not appear across the full cohort, and it was absent in normal-weight participants, but it emerged clearly once excess body weight entered the picture. In practical terms, diet-related inflammatory burden seemed to amplify the metabolic strain already carried by adiposity.
The study drew on 527 Iranian men and women living in Isfahan, with a mean age of 42.66 years. Metabolic health was classified using criteria defined by Wildman and colleagues, and 224 participants, or 42.50%, met the definition of metabolically unhealthy. Dietary intake was assessed with a validated 168-item food frequency questionnaire, a common approach in nutritional epidemiology, while anthropometric, blood pressure, and biochemical measurements were collected using standard methods. Those data were then used to examine whether a more pro-inflammatory dietary pattern corresponded to adverse metabolic status and to two circulating peptides often discussed in energy and glucose biology: brain-derived neurotrophic factor and adropin.
The signal was not uniform. In the fully adjusted model, the overall population did not show a significant association between dietary inflammatory index and metabolic unhealthy status. Normal-weight participants also did not show a meaningful relationship. In the overweight and obesity subgroup, however, people in the third tertile of dietary inflammatory index had significantly higher odds of metabolic unhealthy status than those in the first tertile, with an odds ratio of 2.76 and a 95% confidence interval of 1.16 to 6.57.
Hyperglycemia and hypertriglyceridemia drove the strongest signals
Two metabolic abnormalities stood out. Higher dietary inflammatory index tertiles were associated with hyperglycemia and hypertriglyceridemia, with an odds ratio of 3.41 for the top versus bottom tertile for hyperglycemia and 2.13 for hypertriglyceridemia. Those findings fit a biologically plausible pattern: a more inflammatory diet may aggravate insulin resistance, impair glucose handling, and favor hepatic overproduction of triglyceride-rich lipoproteins, especially in the setting of excess adiposity.
A one-sentence clinical reading is hard to avoid: the diet signal appeared where metabolic stress was already highest. Overweight and obesity likely act as a permissive background for inflammatory pathways to express themselves more clearly, with adipose tissue dysfunction, altered cytokine signaling, and worsening insulin sensitivity creating fertile ground for dysglycemia and dyslipidemia. In leaner participants, the metabolic reserve may have been sufficient to blunt any measurable effect, at least within the limits of this observational design.
The study did not identify a significant association between dietary inflammatory index and either BDNF or adropin. Those null findings matter because both biomarkers have been explored as potential bridges between nutrition, metabolism, and neuroendocrine regulation. BDNF has been linked to energy balance and appetite control, while adropin has been discussed in relation to lipid metabolism and insulin sensitivity. Here, however, dietary inflammatory burden did not translate into a measurable shift in either marker, suggesting that the metabolic effect of diet may be operating through other pathways, or that circulating levels of these peptides are simply not sensitive enough to capture the dietary signal in this population.
Why the association may sharpen in overweight and obesity
The pattern makes physiologic sense even without claiming causality. Dietary patterns with a higher inflammatory load are often richer in components that promote oxidative stress and low-grade systemic inflammation. In an overweight or obese state, baseline inflammation is already elevated, insulin signaling is often impaired, and adipose tissue can behave more like an endocrine organ than a storage depot. Under those conditions, even modest dietary shifts may have greater downstream impact on fasting glucose and triglyceride metabolism.
A further point follows from the outcome definition itself. Metabolic unhealthy status is not a single abnormality but a cluster of derangements, so a diet that worsens glucose homeostasis and lipid handling can tip an already vulnerable person across a diagnostic threshold. The observed associations with hyperglycemia and hypertriglyceridemia fit that framework more neatly than a broad association with the entire cohort.
The study design still leaves important constraints. This was an observational analysis, so the results cannot prove that a pro-inflammatory diet caused worse metabolic health. Dietary intake was estimated with a food frequency questionnaire, which inevitably depends on recall and may misclassify some participants. The work was also conducted in a specific Iranian adult population, so the findings should be interpreted within that cultural and dietary context rather than treated as universal. Even so, the data reinforce a familiar metabolic principle: when body weight is already elevated, the inflammatory quality of the diet may help determine whether dysglycemia and hypertriglyceridemia emerge alongside it.
For clinicians and researchers, the clearest message is not that every inflammatory diet marker will predict every biomarker. It is that diet quality, especially when framed through inflammatory potential, may help distinguish metabolically healthy from metabolically unhealthy obesity. The study leaves open why BDNF and adropin remained unchanged, but it does show that glucose and triglyceride pathways were sensitive to dietary inflammatory burden in this cohort. Future work will need to determine whether those biomarker null results reflect biology, assay limitations, or the challenge of measuring a transient nutritional signal in a cross-sectional snapshot.